Status:
UNKNOWN
Microbial Diversity of Pancreatic Diseases
Lead Sponsor:
Ruijin Hospital
Conditions:
Pancreatic Cancer
Pancreatic Disease
Eligibility:
All Genders
3-85 years
Brief Summary
This study plans to analyze the digestive flora structure of the group of patients with pancreatic cancer. The investigators compared the microflora of pancreatic cancer with other pancreatic disease...
Detailed Description
First, all the participants provided written informed consent for participating in the study. And the collecting procedures have no intervention or impact on treatment measures. Second,the samples ar...
Eligibility Criteria
Inclusion
- Age ≥ 3 years old, ≤ 85 years old;
- After MDT discussion, routine surgery or ERCP can be performed, and the postoperative pathology is clear as pancreatic cancer and other pancreatic diseases;
- There is no serious damage to heart, liver and kidney function;
Exclusion
- Women who are breast-feeding during pregnancy and after pregnancy;
- Patients with evidence of sensory or motor neuropathy;
- Those who have a clear cardiovascular disease, severe associated disease or active infection, including known HIV infection;
- Those who have a history of other cancers;
- Those who are allergic to drugs or their excipients
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT03809247
Start Date
February 1 2019
End Date
December 31 2025
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, Shanghai Municipality, China, 200025